Pentagon Secretly Advancing 'Self-Spreading Vaccine' Development, Documents Reveal


Pentagon Secretly Advancing 'Self-Spreading Vaccine' Development, Documents Reveal

Unsealed documents have revealed that the U.S. Department of Defense (DOD) has been secretly advancing a controversial "self-spreading vaccine" program that critics warn could permanently alter human DNA.

The new documents show that the program has already passed through animal trials, and the next phase involves injecting terminally ill people.

The revelations come from Freedom of Information Act (FOIA) records obtained by the Informed Consent Action Network (ICAN).

TRUTH LIVES on at https://sgtreport.tv/

The files expose details of DARPA's INTERCEPT program.

The records confirm that animal trials have already succeeded, and the Pentagon's next step is to test the technology on humans.

At the center of the program is Autonomous Therapeutics, a biotech company that has already demonstrated its self-spreading vaccine in monkeys.

The company's stated goal is to build "synthetic immune systems" using what they call Therapeutic Interfering Particles (TIPs).

TIPs are genetically engineered viruses designed to act as "tiny Trojan horses," carrying genetic material from person to person without consent.

The documents reveal that DARPA has not only funded the creation of these TIPs but also supported advanced computer modeling to predict how they could move from a single cell to an entire population.

Critics say that once such a product is released into the wild, there is no way to recall, contain, or control it, raising fears that it could spread across borders and generations without oversight.

According to the FOIA records, the Pentagon in 2016 awarded Autonomous Therapeutics a contract to develop a "biological system for replicating human-like conditions" to study the evolutionary dynamics of mutating pathogens.

Co-founder Leor Weinberger has already tested TIPs engineered for HIV on rhesus monkeys and is now pursuing plans to inject them into terminally ill HIV patients.

ICAN warns that the genetic payloads could permanently integrate into patients' DNA and potentially spread well beyond the intended trial population.

Previous articleNext article

POPULAR CATEGORY

corporate

13311

tech

11464

entertainment

16631

research

7753

misc

17461

wellness

13486

athletics

17654